- Home
- AGM vs HRMY Comparison
AGM vs HRMY Comparison
Compare AGM & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AGM | HRMY |
|---|---|---|
| Founded | 1987 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 2.0B |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | AGM | HRMY |
|---|---|---|
| Price | $176.14 | $37.65 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 9 |
| Target Price | ★ $219.00 | $51.33 |
| AVG Volume (30 Days) | 80.5K | ★ 773.7K |
| Earning Date | 11-03-2025 | 11-04-2025 |
| Dividend Yield | ★ 3.37% | N/A |
| EPS Growth | 12.85 | ★ 50.44 |
| EPS | ★ 17.55 | 3.17 |
| Revenue | $377,946,000.00 | ★ $825,944,000.00 |
| Revenue This Year | $14.80 | $23.11 |
| Revenue Next Year | $9.98 | $16.15 |
| P/E Ratio | ★ $10.13 | $11.83 |
| Revenue Growth | 8.81 | ★ 21.13 |
| 52 Week Low | $155.00 | $25.52 |
| 52 Week High | $212.24 | $40.93 |
Technical Indicators
Market Signals| Indicator | AGM | HRMY |
|---|---|---|
| Relative Strength Index (RSI) | 51.98 | 57.57 |
| Support Level | $175.67 | $37.12 |
| Resistance Level | $180.00 | $40.87 |
| Average True Range (ATR) | 4.22 | 1.36 |
| MACD | -0.48 | -0.31 |
| Stochastic Oscillator | 22.01 | 42.99 |
Price Performance
Historical ComparisonAbout AGM Federal Agricultural Mortgage Corporation
Federal Agricultural Mortgage Corp provides agricultural real estate and rural housing mortgage loans in the secondary market in the U.S. Its operations consist of seven segments: Farm & Ranch, Corporate AgFinance, Power & Utilities, Broadband Infrastructure, Renewable Energy, Funding, and Investments. The company purchases eligible mortgage loans secured by first liens on agricultural real estate and rural housing under the Farm & Ranch line of business. Its subsidiary purchases portions of certain agricultural, rural development, business and industry, and community facilities loans guaranteed by the USDA.
About HRMY Harmony Biosciences Holdings Inc.
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.